Physician profile

Lawrence E Stern

Fairfax, VA

NPI 1790776417

$383.46

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$161.06

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Myriad Genetic Laboratories, INC. $130.04 2024 Myrisk
Intuitive Surgical, INC. $92.98 2022
Pacira Pharmaceuticals Incorporated $36.14 2021-2024 Exparel
Stryker Corporation $24.84 2022
Allergan, INC. $24.34 2019
Thd America, INC. $21.71 2019-2023
Covidien LP $19.75 2019
Medtronic, INC. $18.78 2022
Smith+Nephew, INC. $14.88 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Lawrence E Stern

$383.46

in general payments reported 2019-2025

Years
2019-2024
Top company
Myriad Genetic Laboratories, INC.

https://glasscript.com/doctor/307837/lawrence-e-stern

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.